Tag: Samit Hirawat

BMS-986278 succeeds in phase 2 idiopathic pulmonary fibrosis trial, says Bristol Myers Squibb

businessnewstoday- May 22, 2023

Bristol Myers Squibb (BMS) said that BMS-986278 has succeeded in lowering the rate of lung function decline in idiopathic pulmonary fibrosis patients in a phase ... Read More

BMS, bluebird bio bag Abecma FDA approval for multiple myeloma in adults

pallavi123- March 28, 2021

Abecma FDA approval : Bristol Myers Squibb (BMS) and bluebird bio have secured approval from the US Food and Drug Administration (FDA) for Abecma (idecabtagene ... Read More

Novartis breast cancer drug Kisqali plus endocrine therapy extends PFS

pharmanewsdaily- December 9, 2018

Novartis breast cancer drug Kisqali (ribociclib) plus endocrine therapy has succeeded in extending progression-free survival (PFS) compared to only endocrine therapy in three phase 3 ... Read More